Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI), National Institute of Biomedical Imaging and Bioengineering (NIBIB), and National Institute on Drug Abuse (NIDA) intend to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses.
Donor Name: National Institutes of Health
State: All States
County: All Counties
Type of Grant: Grant
Deadline (mm/dd/yyyy): 07/22/2022
Grants Size: $3M
Grant Duration: 3 years
Details:
Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in university laboratories, the NIH also supports innovative technology development in U.S. small businesses through its SBIR and STTR programs. As technologies transition from academic discovery to small businesses, two common challenges arise, identifying the right team with the right expertise to take the product into a small business, and funding for early-stage technology development. This FOA seeks to address both challenges simultaneously by having two equally important goals; entrepreneurial mentoring support, and product development support.
Funding Information
- The following NIH components intend to commit the following amounts in FY 2023:
- NCI, $3M, five to seven awards;
- NIBIB, $1M, one to two awards;
- NIDA, up to $1M, up to three awards.
- NCI will allow applicants to request up to 2 years for phase I and 2 years for phase II.
- NIBIB will allow applicants to request up to 1 year for phase I and 2 years for phase II.
- NIDA will allow applicants to request up to 1 year for phase I and 3 years for phase II.
Eligibility Criteria
- Small businesses
For more information, visit Grants.gov.
